Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(OP:AVAI)

0.3999 -0.0201 (-4.79%)
Streaming Delayed Price Updated: 10:27 AM EDT, Sep 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AVAI

Avant Technologies and JV Partner, Ainnova, Accelerate Expansion Across Latin America Following Key Role at Healthcare Innovation Summit
Las Vegas, NV – April 16, 2025 – Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on... 
Via FinancialNewsMedia
Topics Artificial Intelligence
Avant Technologies and JV Partner, Ainnova, Accelerate Expansion Across Latin America Following Key Role at Healthcare Innovation Summit
Via ACCESS Newswire
Avant Technologies Partner, Ainnova, to Sponsor and Present at 2025 Healthcare Innovation Summit in Mexico City
Via ACCESS Newswire
AI Influence on Medical Diagnostics Generating Billion Dollar Revenues While Growing Adoption Reduces Healthcare Costs
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TEM),(NYSE:TDOC),(NASDAQ:TALK),(NASDAQ:BFRG) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
Avant Technologies and Ainnova Begin Designing Clinical Trial Protocol for Company’s Vision AI Platform
Las Vegas, NV – March 25, 2025 – Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on... 
Via FinancialNewsMedia
Topics Artificial Intelligence
AI Influence on Medical Diagnostics Generating Billion Dollar Revenues While Growing Adoption Reduces Healthcare Costs
From FN Media Group LLC
Via GlobeNewswire
Avant Technologies and Ainnova Begin Designing Clinical Trial Protocol for Company's Vision AI Platform
Via ACCESS Newswire
Artificial Intelligence Influence on Healthcare Industry Reaching All Time Highs for Diagnostics and Treatments
From FN Media Group LLC
Via GlobeNewswire
Artificial Intelligence Influence on Healthcare Industry Reaching All Time Highs for Diagnostics and Treatments
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TEM),(NYSE:TDOC),(NASDAQ:ACON),(NYSE:MDT) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
Avant Technologies and JV Partner, Ainnova, Strategically Align with Apollo Hospitals to Advance AI in Healthcare
Via ACCESS Newswire
Avant Technologies and JV Partner, Ainnova, Strategically Align with Apollo Hospitals to Advance AI in Healthcare
Las Vegas, NV – March 10, 2025 – Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on... 
Via FinancialNewsMedia
Topics Artificial Intelligence
Avant Technologies Reaches Global Development and Licensing Deal with Partner, Ainnova Tech, Ahead of FDA Meetings
Via ACCESS Newswire
Avant Technologies JV Partner to Speak at AI Revolution in Healthcare Summit in Dubai
Via ACCESS Newswire
Artificial Intelligence (AI) Influence on Healthcare Market Expected to Generate Revenues of $610 Billion By 2034
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TEM),(NYSE:BBAI),(NASDAQ:TALK),(NASDAQ:SOUN) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
Avant Technologies and Ainnova Advance Toward FDA Clinical Trial with Selection of Top CRO
Las Vegas, NV – February 11, 2025 – Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”) and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on... 
Via FinancialNewsMedia
Topics Artificial Intelligence
Artificial Intelligence (AI) Influence on Healthcare Market Expected to Generate Revenues of $610 Billion By 2034
From FN Media Group LLC
Via GlobeNewswire
Avant Technologies and Ainnova Advance Toward FDA Clinical Trial with Selection of Top CRO
Via ACCESS Newswire
Avant Technologies to Play Key Role in Ainnova's U.S. FDA Clinical Study for Its Vision AI Platform
LAS VEGAS - January 27, 2025 (NEWMEDIAWIRE) - Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company... 
Via TheNewswire.com
Topics Artificial Intelligence
Avant Technologies to Play Key Role in Ainnova's U.S. FDA Clinical Study for Its Vision AI Platform
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Artificial Intelligence
How HealthCare Industry is Leveraging Artificial Intelligence to Revolutionize Diagnostics and Early Disease Detection
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TEM),(NYSE:MDT),(NYSE:TDOC),(NASDAQ:TALK) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
Avant Technologies and Ainnova Begin Implementing and Testing Advanced AI Algorithms for Early Detection of Additional Diseases
Las Vegas, NV – January 16, 2025 – Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on... 
Via FinancialNewsMedia
Topics Artificial Intelligence
Avant Technologies and Ainnova Begin Implementing and Testing Advanced AI Algorithms for Early Detection of Additional Diseases
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Artificial Intelligence
Avant Technologies and Ainnova Begin Implementing and Testing Advanced AI Algorithms for Early Detection of Additional Diseases
LAS VEGAS - January 16, 2025 (NEWMEDIAWIRE) - Avant Technologies Inc. (OTCQB: AVAI) (“Avant” or the “Company”), and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company... 
Via TheNewswire.com
Topics Artificial Intelligence
The Next Wave of Health AI: Analysts Highlight Breakthroughs in Clinical Trials and Patient Care
USA News Group Commentary Issued on behalf of Avant Technologies Inc. Vancouver, BC – December 17, 2024 – USA News Group News Commentary – Artificial intelligence (AI) is on the brink of becoming a... 
Via FinancialNewsMedia
Topics Artificial Intelligence
Avant Technologies and Ainnova Secure Advanced AI Algorithms for Early Detection of Four Additional Diseases in the U.S.
Las Vegas, NV – December 17, 2024 – Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), and its partner, Ainnova Tech, Inc., (Ainnova) a leading healthcare technology company focused on... 
Via FinancialNewsMedia
Topics Artificial Intelligence
Why Healthcare Providers Are Increasingly Trusting Artificial Intelligence for Detection & Diagnosis
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TEM),(NYSE:MDT),(NYSE:SYK),(NASDAQ:PEGA) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence Climate Change
The Intersection of AI, Medicine, and Stocks: A New Era of Opportunities
EQNX::TICKER_START (OTCQB:AVAI),(OTCQX:RHHBY),(NASDAQ:AMZN),(NASDAQ:MDAI),(NYSE:MDT) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
Why Healthcare Providers Are Increasingly Trusting Artificial Intelligence for Detection & Diagnosis
From FN Media Group LLC
Via GlobeNewswire
Artificial Intelligence (AI) Redefining Medical Diagnostics Industry That’s Expected to be a $7.2 Billion Market by 2029
EQNX::TICKER_START (OTCQB:AVAI),(OTCQX:RHHBY),(NASDAQ:RXRX),(NASDAQ:TEM),(NASDAQ:ISRG) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
Avant Technologies’ Partner, Ainnova, Signs Pilot Program with Roche to Combat Diabetic Retinopathy
Las Vegas, NV – December 4, 2024 – Avant Technologies, Inc.’s (OTCQB: AVAI) (“Avant” or the “Company”), partner, Ainnova Tech, Inc., (Ainnova) a leading healthcare technology company focused on... 
Via FinancialNewsMedia
Topics Artificial Intelligence
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.